Prakash Krishnan - Interventional Cardiology

Biography

Specialties

Interventional Cardiology, Cardiology (Heart), Cardiovascular Disease (Heart Disease)

Education

MD, Rajah Muthiah Medical College

Residency, Internal Medicine, Richmond University Medical Center

Fellowship, Cardiology, Ochsner Medical Center - Main Campus

Fellowship, Interventional Cardiology, Avera Heart Hospital

Fellowship, Interventional Cardiology, Icahn School of Medicine At Mount Sinai

Certifications

American Board of Internal Medicine

Publications

139

Publications

Selected Publications

Impact of Peripheral Arterial Disease on Clinical Outcomes of Patients Undergoing Complex vs Noncomplex Percutaneous Coronary Intervention. Michael Gao, Angelo Oliva, Raman Sharma, Frank Kalaba, Samantha Sartori, Serdar Farhan, Kenneth Smith, Birgit Vogel, Prakash Krishnan, George Dangas, Roxana Mehran, Annapoorna Kini, Samin Sharma. American Journal of Cardiology

Catastrophic Migration of the Axillary IABP Into the Right Renal Artery. Manish Vinayak, Gregory Serrao, Ajit Rao, Johanna Contreras, Samin K. Sharma, Annapoorna S. Kini, Prakash Krishnan, Umesh Gidwani, Anelechi Anyanwu, George D. Dangas. JACC: Cardiovascular Interventions

Chocolate Touch Versus Lutonix Drug-Coated Balloon for Femoropopliteal Lesions in Diabetes: The Chocolate Touch Study. Tanja Böhme, Thomas Zeller, Mehdi H. Shishehbor, Martin Werner, Marianne Brodmann, Helen Parise, Andrew Holden, Michael Lichtenberg, Sahil A. Parikh, Vikram S. Kashyap, Cody Pietras, Daniela Tirziu, Ulrich Beschorner, Prakash Krishnan, Khusrow A. Niazi, Andreas U. Wali, Alexandra J. Lansky. Journal of Endovascular Therapy

View All Publications

Office Locations

The Mount Sinai Hospital

New York, NY 10029

212-241-4643

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Below are financial relationships with industry reported by Dr. Krishnan during 2024 and/or 2025. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership

Abbott
Bard Peripheral Vascular, Inc.
Philips Medical Systems, Inc
Medtronic, Inc

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Below are financial relationships with industry reported by Dr. Krishnan during 2024 and/or 2025. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership

Abbott
Bard Peripheral Vascular, Inc.
Philips Medical Systems, Inc
Medtronic, Inc

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.